Report Detail
Global Depression Drugs Market Size, Status and Forecast 2019-2025
- RnM3036474 |
- 28 February, 2019 |
- Global |
- 95 Pages |
- QYResearch |
- Other
Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.
The classification of Depression Drugs includes SSRIs, SNRIs and others, and the proportion of SSRIs in 2016 is about 47%, and the proportion of SNRIs in 2016 is about 34%.Depression Drugs is widely used in hospitals, clinics and other places. The most proportion of Depression Drugs is hospitals, and the proportion in 2016 is 679%. The trend of hospitals is increasing.
Market competition is not intense. Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, Allergan, GSK, Otsuka Pharmaceutical, Takeda, NHU Group, Shionogi, APOTEX, Kanghong Pharma, HUAHAI, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
In 2018, the global Depression Drugs market size was 15000 million US$ and it is expected to reach 18300 million US$ by the end of 2025, with a CAGR of 2.9% during 2019-2025.
This report focuses on the global Depression Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Depression Drugs development in United States, Europe and China.
The key players covered in this study
Intellipharmaceutics
Pfizer
Eli Lilly
Astrazeneca
Lundbeck
Allergan
GSK
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
APOTEX
Kanghong Pharma
HUAHAI
Market segment by Type, the product can be split into
SSRIs
SNRIs
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Depression Drugs status, future forecast, growth opportunity, key market and key players.
To present the Depression Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Depression Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Depression Drugs Market Size Growth Rate by Type (2014-2025)
- 1.4.2 SSRIs
- 1.4.3 SNRIs
- 1.4.4 Others
- 1.5 Market by Application
- 1.5.1 Global Depression Drugs Market Share by Application (2014-2025)
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Depression Drugs Market Size
- 2.2 Depression Drugs Growth Trends by Regions
- 2.2.1 Depression Drugs Market Size by Regions (2014-2025)
- 2.2.2 Depression Drugs Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Depression Drugs Market Size by Manufacturers
- 3.1.1 Global Depression Drugs Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Depression Drugs Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Depression Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Depression Drugs Key Players Head office and Area Served
- 3.3 Key Players Depression Drugs Product/Solution/Service
- 3.4 Date of Enter into Depression Drugs Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Depression Drugs Market Size by Type (2014-2019)
- 4.2 Global Depression Drugs Market Size by Application (2014-2019)
5 United States
- 5.1 United States Depression Drugs Market Size (2014-2019)
- 5.2 Depression Drugs Key Players in United States
- 5.3 United States Depression Drugs Market Size by Type
- 5.4 United States Depression Drugs Market Size by Application
6 Europe
- 6.1 Europe Depression Drugs Market Size (2014-2019)
- 6.2 Depression Drugs Key Players in Europe
- 6.3 Europe Depression Drugs Market Size by Type
- 6.4 Europe Depression Drugs Market Size by Application
7 China
- 7.1 China Depression Drugs Market Size (2014-2019)
- 7.2 Depression Drugs Key Players in China
- 7.3 China Depression Drugs Market Size by Type
- 7.4 China Depression Drugs Market Size by Application
8 Japan
- 8.1 Japan Depression Drugs Market Size (2014-2019)
- 8.2 Depression Drugs Key Players in Japan
- 8.3 Japan Depression Drugs Market Size by Type
- 8.4 Japan Depression Drugs Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Depression Drugs Market Size (2014-2019)
- 9.2 Depression Drugs Key Players in Southeast Asia
- 9.3 Southeast Asia Depression Drugs Market Size by Type
- 9.4 Southeast Asia Depression Drugs Market Size by Application
10 India
- 10.1 India Depression Drugs Market Size (2014-2019)
- 10.2 Depression Drugs Key Players in India
- 10.3 India Depression Drugs Market Size by Type
- 10.4 India Depression Drugs Market Size by Application
11 Central & South America
- 11.1 Central & South America Depression Drugs Market Size (2014-2019)
- 11.2 Depression Drugs Key Players in Central & South America
- 11.3 Central & South America Depression Drugs Market Size by Type
- 11.4 Central & South America Depression Drugs Market Size by Application
12 International Players Profiles
- 12.1 Intellipharmaceutics
- 12.1.1 Intellipharmaceutics Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Depression Drugs Introduction
- 12.1.4 Intellipharmaceutics Revenue in Depression Drugs Business (2014-2019)
- 12.1.5 Intellipharmaceutics Recent Development
- 12.2 Pfizer
- 12.2.1 Pfizer Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Depression Drugs Introduction
- 12.2.4 Pfizer Revenue in Depression Drugs Business (2014-2019)
- 12.2.5 Pfizer Recent Development
- 12.3 Eli Lilly
- 12.3.1 Eli Lilly Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Depression Drugs Introduction
- 12.3.4 Eli Lilly Revenue in Depression Drugs Business (2014-2019)
- 12.3.5 Eli Lilly Recent Development
- 12.4 Astrazeneca
- 12.4.1 Astrazeneca Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Depression Drugs Introduction
- 12.4.4 Astrazeneca Revenue in Depression Drugs Business (2014-2019)
- 12.4.5 Astrazeneca Recent Development
- 12.5 Lundbeck
- 12.5.1 Lundbeck Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Depression Drugs Introduction
- 12.5.4 Lundbeck Revenue in Depression Drugs Business (2014-2019)
- 12.5.5 Lundbeck Recent Development
- 12.6 Allergan
- 12.6.1 Allergan Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Depression Drugs Introduction
- 12.6.4 Allergan Revenue in Depression Drugs Business (2014-2019)
- 12.6.5 Allergan Recent Development
- 12.7 GSK
- 12.7.1 GSK Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Depression Drugs Introduction
- 12.7.4 GSK Revenue in Depression Drugs Business (2014-2019)
- 12.7.5 GSK Recent Development
- 12.8 Otsuka Pharmaceutical
- 12.8.1 Otsuka Pharmaceutical Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Depression Drugs Introduction
- 12.8.4 Otsuka Pharmaceutical Revenue in Depression Drugs Business (2014-2019)
- 12.8.5 Otsuka Pharmaceutical Recent Development
- 12.9 Takeda
- 12.9.1 Takeda Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Depression Drugs Introduction
- 12.9.4 Takeda Revenue in Depression Drugs Business (2014-2019)
- 12.9.5 Takeda Recent Development
- 12.10 NHU Group
- 12.10.1 NHU Group Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Depression Drugs Introduction
- 12.10.4 NHU Group Revenue in Depression Drugs Business (2014-2019)
- 12.10.5 NHU Group Recent Development
- 12.11 Shionogi
- 12.12 APOTEX
- 12.13 Kanghong Pharma
- 12.14 HUAHAI
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Depression Drugs . Industry analysis & Market Report on Depression Drugs is a syndicated market report, published as Global Depression Drugs Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Depression Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
